Landcent Enters Strategic Partnership with PharmaSymbiosis to Strengthen Market Access Capabilities

Delivering high-impact healthcare solutions requires not only innovation but also a deep understanding of complex and evolving markets. As Landcent’s products are nearing market entry, successfully navigating both public and private sector pathways have become increasingly vital to fulfilling its mission of bringing these solutions to local communities.

To support this effort, Landcent is pleased to announce a strategic partnership with PharmaSymbiosis, aimed at enhancing its access and commercialization strategies across Africa.

About PharmaSymbiosis

PharmaSymbiosis is a healthcare solutions provider with over 70 years of cumulative experience in the pharmaceutical and diagnostics sectors. The company offers a wide range of services, including market research, regulatory filling, health policy development, distribution and post market surveillance. Operating across Sub-Saharan Africa, PharmaSymbiosis partners with international and local stakeholders to address healthcare challenges through compliant, globally aligned solutions.

Advancing Market Access Together

Under the partnership, PharmaSymbiosis will serve as Landcent’s Market Access Implementation Partner, supporting the development and execution of tailored commercial strategies in key markets. In addition to technical expertise, PharmaSymbiosis is expected to provide strategic insights and operational capabilities that will strengthen Landcent’s ability to scale effectively and deliver on its mission.

"Our commitment to impact goes beyond innovation—it is about ensuring access to affordable, life-saving health products and reaching the last mile in their delivery. Partnering with PharmaSymbiosis strengthens our ability to navigate complex markets and enables us to bring life-changing innovations to underserved communities,” said Arun Prabhu Stanley, CEO of Landcent Europe.

“Our collaboration with Landcent is grounded in a shared vision of improving healthcare outcomes. By integrating local market knowledge with innovative health solutions, we aim to create sustainable, scalable impact across the region,” said Charles Fordjour, CEO of PharmaSymbiosis.

Through this partnership, Landcent and PharmaSymbiosis reaffirm their joint commitment to improving access to affordable healthcare innovations and closing the health equity gap.